AU2008308457A1 - Sequencing nucleic acid polymers with electron microscopy - Google Patents
Sequencing nucleic acid polymers with electron microscopy Download PDFInfo
- Publication number
- AU2008308457A1 AU2008308457A1 AU2008308457A AU2008308457A AU2008308457A1 AU 2008308457 A1 AU2008308457 A1 AU 2008308457A1 AU 2008308457 A AU2008308457 A AU 2008308457A AU 2008308457 A AU2008308457 A AU 2008308457A AU 2008308457 A1 AU2008308457 A1 AU 2008308457A1
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- strand
- needle
- base
- strands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims description 322
- 102000039446 nucleic acids Human genes 0.000 title claims description 305
- 108020004707 nucleic acids Proteins 0.000 title claims description 305
- 229920000642 polymer Polymers 0.000 title claims description 75
- 238000001493 electron microscopy Methods 0.000 title description 25
- 238000012163 sequencing technique Methods 0.000 title description 21
- 108020004414 DNA Proteins 0.000 claims description 155
- 238000000034 method Methods 0.000 claims description 137
- 239000000758 substrate Substances 0.000 claims description 125
- 238000003384 imaging method Methods 0.000 claims description 76
- 238000002372 labelling Methods 0.000 claims description 58
- 239000010408 film Substances 0.000 claims description 43
- 150000001875 compounds Chemical class 0.000 claims description 40
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 33
- 229910052799 carbon Inorganic materials 0.000 claims description 33
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 25
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 25
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 25
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 24
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims description 24
- 239000011248 coating agent Substances 0.000 claims description 23
- 238000000576 coating method Methods 0.000 claims description 23
- 239000010409 thin film Substances 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 18
- 239000004793 Polystyrene Substances 0.000 claims description 18
- 238000007598 dipping method Methods 0.000 claims description 18
- 230000015654 memory Effects 0.000 claims description 18
- 229920002223 polystyrene Polymers 0.000 claims description 18
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 17
- 229910052710 silicon Inorganic materials 0.000 claims description 17
- 239000010703 silicon Substances 0.000 claims description 17
- 239000010931 gold Substances 0.000 claims description 13
- 229910052737 gold Inorganic materials 0.000 claims description 12
- 230000027455 binding Effects 0.000 claims description 11
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 108091034117 Oligonucleotide Proteins 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- 229910052790 beryllium Inorganic materials 0.000 claims description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 10
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 9
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 claims description 9
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 claims description 9
- PMBXCGGQNSVESQ-UHFFFAOYSA-N 1-Hexanethiol Chemical compound CCCCCCS PMBXCGGQNSVESQ-UHFFFAOYSA-N 0.000 claims description 8
- 239000011521 glass Substances 0.000 claims description 8
- 150000004767 nitrides Chemical class 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 239000004065 semiconductor Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- KZCOBXFFBQJQHH-UHFFFAOYSA-N octane-1-thiol Chemical compound CCCCCCCCS KZCOBXFFBQJQHH-UHFFFAOYSA-N 0.000 claims description 7
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 claims description 7
- 229910052721 tungsten Inorganic materials 0.000 claims description 7
- 239000010937 tungsten Substances 0.000 claims description 7
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 6
- 229910052796 boron Inorganic materials 0.000 claims description 6
- 229910052762 osmium Inorganic materials 0.000 claims description 6
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 claims description 6
- ZVEZMVFBMOOHAT-UHFFFAOYSA-N nonane-1-thiol Chemical compound CCCCCCCCCS ZVEZMVFBMOOHAT-UHFFFAOYSA-N 0.000 claims description 5
- 230000003287 optical effect Effects 0.000 claims description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 5
- 239000004800 polyvinyl chloride Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 4
- VTXVGVNLYGSIAR-UHFFFAOYSA-N decane-1-thiol Chemical compound CCCCCCCCCCS VTXVGVNLYGSIAR-UHFFFAOYSA-N 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 229910052744 lithium Inorganic materials 0.000 claims description 4
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 102000054765 polymorphisms of proteins Human genes 0.000 claims description 3
- 230000008707 rearrangement Effects 0.000 claims description 3
- 238000002444 silanisation Methods 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims 4
- 239000004926 polymethyl methacrylate Substances 0.000 claims 4
- 229940125782 compound 2 Drugs 0.000 claims 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims 1
- 229910052753 mercury Inorganic materials 0.000 claims 1
- UGFMBZYKVQSQFX-UHFFFAOYSA-N para-methoxy-n-methylamphetamine Chemical compound CNC(C)CC1=CC=C(OC)C=C1 UGFMBZYKVQSQFX-UHFFFAOYSA-N 0.000 claims 1
- 229920000915 polyvinyl chloride Polymers 0.000 claims 1
- 239000000243 solution Substances 0.000 description 115
- 102000053602 DNA Human genes 0.000 description 60
- 125000004429 atom Chemical group 0.000 description 32
- 239000000523 sample Substances 0.000 description 22
- -1 PMMA Substances 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 238000013459 approach Methods 0.000 description 14
- 230000000295 complement effect Effects 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- 239000002872 contrast media Substances 0.000 description 10
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 10
- 238000000151 deposition Methods 0.000 description 10
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 10
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 9
- 238000010023 transfer printing Methods 0.000 description 9
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 7
- BRMYZIKAHFEUFJ-UHFFFAOYSA-L mercury diacetate Chemical compound CC(=O)O[Hg]OC(C)=O BRMYZIKAHFEUFJ-UHFFFAOYSA-L 0.000 description 7
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 7
- 239000012285 osmium tetroxide Substances 0.000 description 7
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000007984 Tris EDTA buffer Substances 0.000 description 6
- 238000003491 array Methods 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 5
- 108020004682 Single-Stranded DNA Proteins 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- 238000011109 contamination Methods 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 102000040430 polynucleotide Human genes 0.000 description 5
- 108091033319 polynucleotide Proteins 0.000 description 5
- 239000002157 polynucleotide Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 229930024421 Adenine Natural products 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 229960000643 adenine Drugs 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 238000010894 electron beam technology Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 229910052618 mica group Inorganic materials 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 238000007639 printing Methods 0.000 description 4
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000003508 chemical denaturation Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229940104302 cytosine Drugs 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
- 230000005499 meniscus Effects 0.000 description 3
- GZAJJDUWYRDMPO-UHFFFAOYSA-N methylsulfinylmethane;platinum Chemical compound [Pt].CS(C)=O GZAJJDUWYRDMPO-UHFFFAOYSA-N 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 2
- HWPZZUQOWRWFDB-UHFFFAOYSA-N 1-methylcytosine Chemical compound CN1C=CC(N)=NC1=O HWPZZUQOWRWFDB-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000003749 cleanliness Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 125000001273 sulfonato group Chemical class [O-]S(*)(=O)=O 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- DKPSSMOJHLISJI-UHFFFAOYSA-N 1,10-phenanthrolin-5-amine Chemical compound C1=CC=C2C(N)=CC3=CC=CN=C3C2=N1 DKPSSMOJHLISJI-UHFFFAOYSA-N 0.000 description 1
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical group OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 1
- MGTWMTLYXJBPJE-UHFFFAOYSA-N 2-diphenylphosphanylpropanoic acid Chemical compound C=1C=CC=CC=1P(C(C)C(O)=O)C1=CC=CC=C1 MGTWMTLYXJBPJE-UHFFFAOYSA-N 0.000 description 1
- FRWYFWZENXDZMU-UHFFFAOYSA-N 2-iodoquinoline Chemical compound C1=CC=CC2=NC(I)=CC=C21 FRWYFWZENXDZMU-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 108091029845 Aminoallyl nucleotide Proteins 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 230000030933 DNA methylation on cytosine Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000156978 Erebia Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 102000006391 Ion Pumps Human genes 0.000 description 1
- 108010083687 Ion Pumps Proteins 0.000 description 1
- 241000276489 Merlangius merlangus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 241000204795 Muraena helena Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 230000000397 acetylating effect Effects 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- LTPBRCUWZOMYOC-UHFFFAOYSA-N beryllium oxide Inorganic materials O=[Be] LTPBRCUWZOMYOC-UHFFFAOYSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- XWDKRVSSHIJNJP-UHFFFAOYSA-N carbon monoxide;iridium Chemical group [Ir].[Ir].[Ir].[Ir].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-] XWDKRVSSHIJNJP-UHFFFAOYSA-N 0.000 description 1
- VUBLMKVEIPBYME-UHFFFAOYSA-N carbon monoxide;osmium Chemical group [Os].[Os].[Os].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-].[O+]#[C-] VUBLMKVEIPBYME-UHFFFAOYSA-N 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000004320 controlled atmosphere Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001803 electron scattering Methods 0.000 description 1
- 230000004049 epigenetic modification Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001424 field-emission electron microscopy Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- ORTRWBYBJVGVQC-UHFFFAOYSA-N hexadecane-1-thiol Chemical compound CCCCCCCCCCCCCCCCS ORTRWBYBJVGVQC-UHFFFAOYSA-N 0.000 description 1
- 238000000731 high angular annular dark-field scanning transmission electron microscopy Methods 0.000 description 1
- 238000001239 high-resolution electron microscopy Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 239000002122 magnetic nanoparticle Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 238000001393 microlithography Methods 0.000 description 1
- 238000005459 micromachining Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004549 pulsed laser deposition Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000001350 scanning transmission electron microscopy Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- MRXYMLOJPVRIMT-UHFFFAOYSA-N trinitrooxymethyl nitrate Chemical compound [O-][N+](=O)OC(O[N+]([O-])=O)(O[N+]([O-])=O)O[N+]([O-])=O MRXYMLOJPVRIMT-UHFFFAOYSA-N 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/60—Detection means characterised by use of a special device
- C12Q2565/601—Detection means characterised by use of a special device being a microscope, e.g. atomic force microscopy [AFM]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99742707P | 2007-10-04 | 2007-10-04 | |
| US60/997,427 | 2007-10-04 | ||
| US13296008P | 2008-06-23 | 2008-06-23 | |
| US61/132,960 | 2008-06-23 | ||
| PCT/US2008/078986 WO2009046445A1 (en) | 2007-10-04 | 2008-10-06 | Sequencing nucleic acid polymers with electron microscopy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2008308457A1 true AU2008308457A1 (en) | 2009-04-09 |
Family
ID=40526732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008308457A Abandoned AU2008308457A1 (en) | 2007-10-04 | 2008-10-06 | Sequencing nucleic acid polymers with electron microscopy |
Country Status (12)
| Country | Link |
|---|---|
| US (8) | US20100331195A1 (enExample) |
| EP (1) | EP2203547A4 (enExample) |
| JP (1) | JP2010539991A (enExample) |
| KR (1) | KR20100089060A (enExample) |
| CN (1) | CN101889074A (enExample) |
| AU (1) | AU2008308457A1 (enExample) |
| CA (1) | CA2701726A1 (enExample) |
| EA (1) | EA201000427A1 (enExample) |
| IL (1) | IL204866A0 (enExample) |
| MX (1) | MX2010003724A (enExample) |
| WO (1) | WO2009046445A1 (enExample) |
| ZA (1) | ZA201002881B (enExample) |
Families Citing this family (109)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8021841B1 (en) * | 2007-07-11 | 2011-09-20 | Kenneth David Schatz | Methods and apparatuses for spatially separating molecules attached to a support and uses in biotechnology |
| US7888127B2 (en) | 2008-01-15 | 2011-02-15 | Sequenom, Inc. | Methods for reducing adduct formation for mass spectrometry analysis |
| EP3216874A1 (en) | 2008-09-05 | 2017-09-13 | TOMA Biosciences, Inc. | Methods for stratifying and annotating cancer drug treatment options |
| US8962247B2 (en) | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
| US8476013B2 (en) | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| EP3088532B1 (en) | 2009-12-22 | 2019-10-30 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
| WO2011090556A1 (en) | 2010-01-19 | 2011-07-28 | Verinata Health, Inc. | Methods for determining fraction of fetal nucleic acid in maternal samples |
| US10388403B2 (en) | 2010-01-19 | 2019-08-20 | Verinata Health, Inc. | Analyzing copy number variation in the detection of cancer |
| US10662474B2 (en) | 2010-01-19 | 2020-05-26 | Verinata Health, Inc. | Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing |
| WO2012135730A2 (en) | 2011-03-30 | 2012-10-04 | Verinata Health, Inc. | Method for verifying bioassay samples |
| US8700341B2 (en) | 2010-01-19 | 2014-04-15 | Verinata Health, Inc. | Partition defined detection methods |
| EP3006573B1 (en) | 2010-01-19 | 2018-03-07 | Verinata Health, Inc | Methods for determining fraction of fetal nucleic acids in maternal samples |
| US9323888B2 (en) | 2010-01-19 | 2016-04-26 | Verinata Health, Inc. | Detecting and classifying copy number variation |
| US20120100548A1 (en) | 2010-10-26 | 2012-04-26 | Verinata Health, Inc. | Method for determining copy number variations |
| US9260745B2 (en) | 2010-01-19 | 2016-02-16 | Verinata Health, Inc. | Detecting and classifying copy number variation |
| TW201137923A (en) | 2010-02-10 | 2011-11-01 | Halcyon Molecular Inc | Aberration-correcting dark-field electron microscopy |
| IN2013MN00522A (enExample) | 2010-09-24 | 2015-05-29 | Univ Leland Stanford Junior | |
| WO2012064850A1 (en) * | 2010-11-09 | 2012-05-18 | Michael Andregg | Liquid-gas interface mediated molecule manipulation |
| WO2012125547A2 (en) * | 2011-03-11 | 2012-09-20 | Cornell University | Systems and methods for high resolution biomolecular imaging and analysis |
| DK2697392T3 (en) | 2011-04-12 | 2016-03-29 | Verinata Health Inc | SOLUTION OF GENOME FRACTIONS USING Polymorphism COUNTS |
| WO2012141712A1 (en) | 2011-04-14 | 2012-10-18 | Verinata Health, Inc. | Normalizing chromosomes for the determination and verification of common and rare chromosomal aneuploidies |
| US9411937B2 (en) | 2011-04-15 | 2016-08-09 | Verinata Health, Inc. | Detecting and classifying copy number variation |
| WO2014014498A1 (en) | 2012-07-20 | 2014-01-23 | Verinata Health, Inc. | Detecting and classifying copy number variation in a fetal genome |
| US20140235474A1 (en) | 2011-06-24 | 2014-08-21 | Sequenom, Inc. | Methods and processes for non invasive assessment of a genetic variation |
| US20130029348A1 (en) * | 2011-07-26 | 2013-01-31 | Opgen, Inc. | Methods of elongating nucleic acids |
| CN103003447B (zh) | 2011-07-26 | 2020-08-25 | 维里纳塔健康公司 | 用于确定样品中存在或不存在不同非整倍性的方法 |
| US10196681B2 (en) | 2011-10-06 | 2019-02-05 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9984198B2 (en) | 2011-10-06 | 2018-05-29 | Sequenom, Inc. | Reducing sequence read count error in assessment of complex genetic variations |
| US20140242588A1 (en) | 2011-10-06 | 2014-08-28 | Sequenom, Inc | Methods and processes for non-invasive assessment of genetic variations |
| US10424394B2 (en) | 2011-10-06 | 2019-09-24 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| AU2012318371B2 (en) | 2011-10-06 | 2018-03-22 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9367663B2 (en) | 2011-10-06 | 2016-06-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| CA2851537C (en) | 2011-10-11 | 2020-12-29 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US8688388B2 (en) | 2011-10-11 | 2014-04-01 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US10501791B2 (en) | 2011-10-14 | 2019-12-10 | President And Fellows Of Harvard College | Sequencing by structure assembly |
| WO2013063126A2 (en) * | 2011-10-25 | 2013-05-02 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | Programmable arrays |
| JP2014176297A (ja) * | 2011-11-11 | 2014-09-25 | Nagayama Ip Holdings Llc | 塩基対応標識方法、塩基配列情報取得方法及び塩基対応標識化一本鎖核酸 |
| JP6034801B2 (ja) * | 2011-11-15 | 2016-11-30 | ナガヤマ アイピー ホールディングス エルエルシーＮａｇａｙａｍａ ＩＰ Ｈｏｌｄｉｎｇｓ， ＬＬＣ | 塩基配列決定装置 |
| ES2991004T3 (es) | 2011-12-22 | 2024-12-02 | Harvard College | Métodos para la detección de analitos |
| ES2953308T3 (es) | 2011-12-22 | 2023-11-10 | Harvard College | Composiciones y métodos para la detección de analitos |
| WO2014163886A1 (en) | 2013-03-12 | 2014-10-09 | President And Fellows Of Harvard College | Method of generating a three-dimensional nucleic acid containing matrix |
| US8858778B2 (en) * | 2012-01-19 | 2014-10-14 | Michael James Darling | Method for DNA defined etching of a graphene nanostructure |
| HUE059847T2 (hu) | 2012-01-20 | 2023-01-28 | Sequenom Inc | Kísérleti körülményeket fakturáló diagnosztikai folyamatok |
| US9856513B2 (en) * | 2012-01-27 | 2018-01-02 | Cornell University | Methods and arrays for controlled manipulation of DNA and chromatin fragments for genetic and epigenetic analysis |
| EP3401399B1 (en) | 2012-03-02 | 2020-04-22 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
| US9914967B2 (en) | 2012-06-05 | 2018-03-13 | President And Fellows Of Harvard College | Spatial sequencing of nucleic acids using DNA origami probes |
| US10497461B2 (en) | 2012-06-22 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| JP2015521862A (ja) | 2012-07-13 | 2015-08-03 | セクエノム， インコーポレイテッド | 非侵襲性の出生前診断に有用な母体サンプル由来の胎児核酸のメチル化に基づく富化のためのプロセスおよび組成物 |
| US10482994B2 (en) | 2012-10-04 | 2019-11-19 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| CA2887094C (en) | 2012-10-04 | 2021-09-07 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| CN105074463B (zh) | 2013-01-31 | 2018-09-25 | 科德克希思公司 | 使用相乘形式的模型鉴定生物分子的方法、系统和软件 |
| US20130189684A1 (en) | 2013-03-12 | 2013-07-25 | Sequenom, Inc. | Quantification of cell-specific nucleic acid markers |
| EP3597774A1 (en) | 2013-03-13 | 2020-01-22 | Sequenom, Inc. | Primers for dna methylation analysis |
| US9305756B2 (en) | 2013-03-13 | 2016-04-05 | Agena Bioscience, Inc. | Preparation enhancements and methods of use for MALDI mass spectrometry |
| CA2906818C (en) | 2013-03-15 | 2022-08-16 | Verinata Health, Inc. | Generating cell-free dna libraries directly from blood |
| WO2014165596A1 (en) | 2013-04-03 | 2014-10-09 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US20140336055A1 (en) | 2013-05-07 | 2014-11-13 | Sequenom, Inc. | Genetic markers for macular degeneration disorder treatment |
| WO2014190286A2 (en) | 2013-05-24 | 2014-11-27 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| MY177814A (en) | 2013-06-04 | 2020-09-23 | Harvard College | Rna-guided transcriptional regulation |
| CA2915626A1 (en) | 2013-06-17 | 2014-12-24 | Verinata Health, Inc. | Method for determining copy number variations in sex chromosomes |
| DK3011051T3 (en) | 2013-06-21 | 2019-04-23 | Sequenom Inc | Method for non-invasive evaluation of genetic variations |
| EP3418929B1 (en) | 2013-09-27 | 2020-12-09 | Codexis, Inc. | Automated screening of enzyme variants |
| KR102514024B1 (ko) | 2013-10-04 | 2023-03-23 | 시쿼넘, 인코포레이티드 | 유전적 변이의 비침습 평가를 위한 방법 및 프로세스 |
| CN111863131A (zh) | 2013-10-07 | 2020-10-30 | 塞昆纳姆股份有限公司 | 用于非侵入性评估染色体改变的方法和过程 |
| KR102373647B1 (ko) | 2013-10-21 | 2022-03-11 | 베리나타 헬스, 인코포레이티드 | 사본수 변동을 결정함에 있어서 검출의 감수성을 향상시키기 위한 방법 |
| EP3077545B1 (en) | 2013-12-05 | 2020-09-16 | Centrillion Technology Holdings Corporation | Methods for sequencing nucleic acids |
| CN106460032B (zh) | 2013-12-05 | 2019-12-24 | 生捷科技控股公司 | 图案化阵列的制备 |
| WO2015085268A1 (en) | 2013-12-05 | 2015-06-11 | Centrillion Technology Holdings Corporation | Modified surfaces |
| JP6666852B2 (ja) | 2014-01-16 | 2020-03-18 | イルミナ インコーポレイテッド | 前立腺がん再発の予後に関する遺伝子発現パネル |
| WO2015138774A1 (en) | 2014-03-13 | 2015-09-17 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US11060139B2 (en) | 2014-03-28 | 2021-07-13 | Centrillion Technology Holdings Corporation | Methods for sequencing nucleic acids |
| US10318704B2 (en) | 2014-05-30 | 2019-06-11 | Verinata Health, Inc. | Detecting fetal sub-chromosomal aneuploidies |
| US10179932B2 (en) | 2014-07-11 | 2019-01-15 | President And Fellows Of Harvard College | Methods for high-throughput labelling and detection of biological features in situ using microscopy |
| US10119167B2 (en) | 2014-07-18 | 2018-11-06 | Illumina, Inc. | Non-invasive prenatal diagnosis of fetal genetic condition using cellular DNA and cell free DNA |
| ES3047391T3 (en) | 2014-07-30 | 2025-12-03 | Sequenom Inc | Methods and processes for non-invasive assessment of genetic variations |
| US20160032281A1 (en) * | 2014-07-31 | 2016-02-04 | Fei Company | Functionalized grids for locating and imaging biological specimens and methods of using the same |
| JP6694429B2 (ja) | 2014-10-09 | 2020-05-13 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 上皮細胞増殖因子受容体キナーゼドメインにおける変異 |
| US11789906B2 (en) | 2014-11-19 | 2023-10-17 | Arc Bio, Llc | Systems and methods for genomic manipulations and analysis |
| EP3567120B1 (en) | 2014-12-12 | 2020-08-19 | Verinata Health, Inc. | Using cell-free dna fragment size to determine copy number variations |
| CN104630346A (zh) * | 2015-01-05 | 2015-05-20 | 东南大学 | 基于高分辨透射电子显微学的单分子dna测序方法 |
| DK3332034T3 (da) | 2015-08-06 | 2024-10-28 | Arc Bio Llc | Systemer og fremgangsmåder til genomisk analyse |
| US10774375B2 (en) | 2015-09-18 | 2020-09-15 | Agena Bioscience, Inc. | Methods and compositions for the quantitation of mitochondrial nucleic acid |
| GB2559526B (en) | 2015-11-03 | 2021-02-17 | Harvard College | Method and apparatus for volumetric imaging of a three-dimensional nucleic acid containing matrix |
| US10095831B2 (en) | 2016-02-03 | 2018-10-09 | Verinata Health, Inc. | Using cell-free DNA fragment size to determine copy number variations |
| US9989482B2 (en) * | 2016-02-16 | 2018-06-05 | General Electric Company | Methods for radiographic and CT inspection of additively manufactured workpieces |
| EP4613756A3 (en) | 2016-04-25 | 2025-11-12 | President And Fellows Of Harvard College | Hybridization chain reaction methods for in situ molecular detection |
| EP3491560A1 (en) | 2016-07-27 | 2019-06-05 | Sequenom, Inc. | Genetic copy number alteration classifications |
| CN118853848A (zh) | 2016-08-31 | 2024-10-29 | 哈佛学院董事及会员团体 | 将生物分子的检测组合到使用荧光原位测序的单个试验的方法 |
| GB2570412A (en) | 2016-08-31 | 2019-07-24 | Harvard College | Methods of generating libraries of nucleic acid sequences for detection via fluorescent in situ sequencing |
| JP6730525B2 (ja) | 2016-11-21 | 2020-07-29 | ナノストリング テクノロジーズ，インコーポレイティド | 化学組成物とそれを利用する方法 |
| CA3207879A1 (en) | 2017-01-24 | 2018-08-02 | Sequenom, Inc. | Methods and processes for assessment of genetic variations |
| JP7024490B2 (ja) * | 2017-02-27 | 2022-02-24 | 住友金属鉱山株式会社 | 汚染堆積物の定量方法および試料分析方法 |
| EP3998350B1 (en) | 2017-03-17 | 2025-05-07 | Sequenom, Inc. | Methods and processes for assessment of genetic mosaicism |
| CN109789167A (zh) | 2017-04-14 | 2019-05-21 | 哈佛学院董事及会员团体 | 用于产生细胞衍生的微丝网络的方法 |
| US11342047B2 (en) | 2017-04-21 | 2022-05-24 | Illumina, Inc. | Using cell-free DNA fragment size to detect tumor-associated variant |
| SG11201911530RA (en) | 2017-06-20 | 2020-01-30 | Illumina Inc | Methods for accurate computational decomposition of dna mixtures from contributors of unknown genotypes |
| WO2018236911A1 (en) | 2017-06-20 | 2018-12-27 | Illumina, Inc. | Methods and systems for decomposition and quantification of dna mixtures from multiple contributors of known or unknown genotypes |
| KR102805731B1 (ko) | 2017-12-01 | 2025-06-19 | 일루미나, 인코포레이티드 | 체성 돌연변이 클론형성능을 결정하기 위한 방법 및 시스템 |
| JP7525402B2 (ja) | 2018-05-14 | 2024-07-30 | ナノストリング テクノロジーズ，インコーポレイティド | 化学的組成物とそれを利用する方法 |
| SG11202101934SA (en) | 2018-07-30 | 2021-03-30 | Readcoor Llc | Methods and systems for sample processing or analysis |
| WO2020076976A1 (en) | 2018-10-10 | 2020-04-16 | Readcoor, Inc. | Three-dimensional spatial molecular indexing |
| CN111324096B (zh) * | 2020-03-03 | 2021-04-23 | 郑州旭飞光电科技有限公司 | 一种基板玻璃加工、包装信息可追溯系统及方法 |
| CN111537529A (zh) * | 2020-04-09 | 2020-08-14 | 中国科学院微电子研究所 | 一种用于附着穿透式电子显微镜样品的硅网及其制备方法 |
| US20220049303A1 (en) | 2020-08-17 | 2022-02-17 | Readcoor, Llc | Methods and systems for spatial mapping of genetic variants |
| WO2022164968A1 (en) | 2021-01-29 | 2022-08-04 | Day Zero Diagnostics, Inc. | Methods for enriching microorganisms from low abundance clinical samples for dna sequencing |
| WO2024249175A1 (en) | 2023-05-26 | 2024-12-05 | Illumina, Inc. | Methods for discriminating between fetal and maternal events in non-invasive prenatal test samples |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4689295A (en) * | 1983-01-20 | 1987-08-25 | Integrated Genetics, Inc. | Test for Salmonella |
| US6221581B1 (en) * | 1984-04-27 | 2001-04-24 | Enzo Diagnostics, Inc. | Processes for detecting polynucleotides, determining genetic mutations or defects in genetic material, separating or isolating nucleic acid of interest from samples, and useful compositions of matter and multihybrid complex compositions |
| US5447841A (en) * | 1986-01-16 | 1995-09-05 | The Regents Of The Univ. Of California | Methods for chromosome-specific staining |
| US6150089A (en) * | 1988-09-15 | 2000-11-21 | New York University | Method and characterizing polymer molecules or the like |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US5106729A (en) * | 1989-07-24 | 1992-04-21 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Method for visualizing the base sequence of nucleic acid polymers |
| US5789161A (en) * | 1990-09-20 | 1998-08-04 | Amoco Corporation | Methods for genome identification using direct label probe composition |
| JPH05244997A (ja) | 1992-03-04 | 1993-09-24 | Hitachi Ltd | Ｄｎａまたはｒｎａの塩基配列決定法 |
| US5871912A (en) * | 1992-04-30 | 1999-02-16 | Institut Pasteur | Nucleic acid probes, sequences and methods for detecting mycobacterium tuberculosis resistant to isoniazid |
| US5472881A (en) | 1992-11-12 | 1995-12-05 | University Of Utah Research Foundation | Thiol labeling of DNA for attachment to gold surfaces |
| CA2155186A1 (en) * | 1993-02-01 | 1994-08-18 | Kevin M. Ulmer | Methods and apparatus for dna sequencing |
| GB9401200D0 (en) * | 1994-01-21 | 1994-03-16 | Medical Res Council | Sequencing of nucleic acids |
| US20020168642A1 (en) * | 1994-06-06 | 2002-11-14 | Andrzej Drukier | Sequencing duplex DNA by mass spectroscopy |
| WO1996009410A1 (en) * | 1994-09-23 | 1996-03-28 | Finkelstein Sydney D | Topographic genotyping |
| US5601982A (en) * | 1995-02-07 | 1997-02-11 | Sargent; Jeannine P. | Method and apparatus for determining the sequence of polynucleotides |
| US5843650A (en) * | 1995-05-01 | 1998-12-01 | Segev; David | Nucleic acid detection and amplification by chemical linkage of oligonucleotides |
| US6852487B1 (en) * | 1996-02-09 | 2005-02-08 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| EP0912761A4 (en) | 1996-05-29 | 2004-06-09 | Cornell Res Foundation Inc | DETERMINATION OF DIFFERENCES IN THE NUCLEIC ACID SEQUENCE BY MEANS OF A COMBINATION OF LIGASE DETERMINATION AND POLYMERASE CHAIN REACTION |
| US6582921B2 (en) * | 1996-07-29 | 2003-06-24 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses thereof |
| GB9620209D0 (en) * | 1996-09-27 | 1996-11-13 | Cemu Bioteknik Ab | Method of sequencing DNA |
| US6136543A (en) * | 1997-01-31 | 2000-10-24 | Hitachi, Ltd. | Method for determining nucleic acids base sequence and apparatus therefor |
| CA2205081A1 (en) * | 1997-06-04 | 1998-12-04 | Graham Dellaire | A method to map and isolate regions of chromosomes that interact or associate functionally within or between chromosomes in vivo |
| US5903085A (en) * | 1997-06-18 | 1999-05-11 | Phase Metrics, Inc. | Piezoelectric nanopositioner |
| DE19900511C2 (de) * | 1999-01-08 | 2001-03-15 | Deutsches Krebsforsch | Molekularbiologische Marker für die analytische Elektronenmikroskopie |
| WO2000075868A2 (en) * | 1999-06-07 | 2000-12-14 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for use in three-dimensional structural determination |
| DE19937512B4 (de) * | 1999-08-09 | 2006-08-24 | Alexander Cherkasky | Verfahren und Gerät zur schnellen Genom-Sequenzierung durch Linearisierung oder Auseinanderziehen der DNA |
| US7244559B2 (en) * | 1999-09-16 | 2007-07-17 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
| US7211390B2 (en) | 1999-09-16 | 2007-05-01 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
| EP1303639A2 (en) | 2000-04-14 | 2003-04-23 | Cornell Research Foundation, Inc. | Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction |
| JP2002153271A (ja) * | 2000-11-17 | 2002-05-28 | Jeol Ltd | Ｄｎａあるいはｒｎａの塩基配列決定方法およびｄｎａシーケンサー |
| US7419833B2 (en) * | 2000-11-17 | 2008-09-02 | Nagayama Ip Holdings Llc | Method for nucleic acid sequencing |
| WO2002044425A2 (en) * | 2000-12-01 | 2002-06-06 | Visigen Biotechnologies, Inc. | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
| AU2002239581B2 (en) * | 2000-12-15 | 2006-09-28 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method for patterning metal using nanoparticle containing precursors |
| DK1370690T3 (da) * | 2001-03-16 | 2012-07-09 | Kalim Mir | Arrays og fremgangsmåder til anvendelse heraf |
| WO2002075306A1 (en) * | 2001-03-16 | 2002-09-26 | Large Scale Biology Corporation | Episomal non-transforming nucleic acid elements in functional genomic and antigenic applications |
| FR2823223B1 (fr) * | 2001-04-04 | 2004-03-12 | Centre Nat Rech Scient | Structure bicouche supportee de presentation d'un acide nucleique associe a une proteine |
| GB0112238D0 (en) * | 2001-05-18 | 2001-07-11 | Medical Biosystems Ltd | Sequencing method |
| GB2378245A (en) | 2001-08-03 | 2003-02-05 | Mats Nilsson | Nucleic acid amplification method |
| AU2002332846A1 (en) * | 2001-09-07 | 2003-04-07 | Boston University | Lanthanide binding tags |
| FR2829580B1 (fr) * | 2001-09-07 | 2004-02-13 | Bio Merieux | Procede de lecture, de detection ou de quantification, hybrides ou complexes utilises dans ce procede et biopuce mettant en oeuvre ledit procede |
| US20040086885A1 (en) * | 2002-02-22 | 2004-05-06 | Purdue Research Foundation | Magnetic nanomaterials and methods for detection of biological materials |
| JP4120240B2 (ja) * | 2002-03-06 | 2008-07-16 | 株式会社島津製作所 | 生体由来異物検査法 |
| US20060003437A1 (en) * | 2002-06-26 | 2006-01-05 | Fujitsu Limited | Target detecting device and target capturer, device and method for molecular adsorption or desorption, and device and method for protein detection |
| US20040081985A1 (en) * | 2002-07-12 | 2004-04-29 | Affymetrix, Inc. | Systems and method for examination of microarrays using scanning electron microscope |
| US20050009055A1 (en) * | 2002-07-12 | 2005-01-13 | Affymetrix, Inc. | System and method for examination of microarrays using scanning electron microscope |
| AU2003267583A1 (en) * | 2002-09-19 | 2004-04-08 | The Chancellor, Master And Scholars Of The University Of Oxford | Molecular arrays and single molecule detection |
| EP1424671A1 (en) * | 2002-11-29 | 2004-06-02 | Alrec Sign & Display B.V. | Illuminated sign |
| JP2004212355A (ja) | 2003-01-09 | 2004-07-29 | Hitachi Ltd | バイオ電子顕微鏡及び試料の観察方法 |
| US7745116B2 (en) * | 2003-04-08 | 2010-06-29 | Pacific Biosciences Of California, Inc. | Composition and method for nucleic acid sequencing |
| US20100035254A1 (en) * | 2003-04-08 | 2010-02-11 | Pacific Biosciences Of California, Inc. | Composition and method for nucleic acid sequencing |
| EP1618210B1 (en) * | 2003-04-21 | 2010-09-01 | Roche Diagnostics GmbH | Associations of polymorphisms in the frzb gene with osteoporosis |
| US7625346B2 (en) * | 2003-05-30 | 2009-12-01 | Boston Scientific Scimed, Inc. | Transbronchial needle aspiration device |
| WO2005052582A2 (en) * | 2003-11-28 | 2005-06-09 | Pamgene B.V. | Methods and apparatus for cell based microarray assays |
| US20050147977A1 (en) * | 2003-12-29 | 2005-07-07 | Tae-Woong Koo | Methods and compositions for nucleic acid detection and sequence analysis |
| US7381529B2 (en) * | 2003-12-31 | 2008-06-03 | Intel Corporation | Methods and compositions for detecting nucleic acids using scanning probe microscopy and nanocodes |
| US7154091B2 (en) * | 2004-04-02 | 2006-12-26 | California Institute Of Technology | Method and system for ultrafast photoelectron microscope |
| WO2005118877A2 (en) | 2004-06-02 | 2005-12-15 | Vicus Bioscience, Llc | Producing, cataloging and classifying sequence tags |
| JP5224443B2 (ja) | 2004-07-14 | 2013-07-03 | ゼットエス ジェネティクス，インコーポレーテッド | 核酸ポリマーの分析システムおよび方法および関連構成要素 |
| JP4563117B2 (ja) * | 2004-09-03 | 2010-10-13 | エスアイアイ・ナノテクノロジー株式会社 | 顕微鏡システム及び顕微鏡システムの走査法ならびに顕微鏡システムの画像合成法 |
| WO2006118615A2 (en) * | 2004-12-16 | 2006-11-09 | Brandeis University | Clonable tag for purification and electron microscopy labeling |
| US7875426B2 (en) * | 2005-02-04 | 2011-01-25 | University Of South Florida | DNA biochip and methods of use |
| JP2006262834A (ja) * | 2005-03-25 | 2006-10-05 | Canon Inc | 核酸の塩基配列の決定方法及び該方法に基づく核酸の塩基配列解析装置 |
| US20060287833A1 (en) * | 2005-06-17 | 2006-12-21 | Zohar Yakhini | Method and system for sequencing nucleic acid molecules using sequencing by hybridization and comparison with decoration patterns |
| US20090031444A1 (en) * | 2005-09-09 | 2009-01-29 | Peter Egbertus Wittich | Homologous recombination in plants |
| EP1954828A2 (en) * | 2005-10-27 | 2008-08-13 | The Trustees Of Boston University | Real time nucleic acid detection in vivo using protein complementation |
| US20070134699A1 (en) * | 2005-11-09 | 2007-06-14 | Zs Genetics, Inc. | Nano-scale ligand arrays on substrates for particle beam instruments and related methods |
| EP1951890A4 (en) * | 2005-11-16 | 2009-06-24 | Ambrx Inc | PROCESSES AND COMPOSITIONS WITH NON-NATURAL AMINO ACIDS |
| US20070128610A1 (en) * | 2005-12-02 | 2007-06-07 | Buzby Philip R | Sample preparation method and apparatus for nucleic acid sequencing |
| US20070190557A1 (en) * | 2006-01-27 | 2007-08-16 | Zs Genetics, Inc. | Systems and methods of analyzing nucleic acid polymers and related components |
| ES2301342B1 (es) * | 2006-03-14 | 2009-05-01 | Oryzon Genomics, S.A. | "metodo de analisis de acidos nucleicos". |
| DE502006005397D1 (de) * | 2006-03-25 | 2009-12-31 | Univ Ruprecht Karls Heidelberg | Verfahren zur mikroskopischen Ortsbestimmung eines ausgewählten, intrazellulären DNA-Abschnitts bekannter Nukleotidsequenz |
| JP5092462B2 (ja) * | 2006-06-13 | 2012-12-05 | 株式会社デンソー | 力学量センサ |
| US8685658B2 (en) * | 2006-07-17 | 2014-04-01 | Fox Chase Cancer Center | Compositions and methods for the treatment of diseases associated with aberrant cilia assembly and regulation |
| CN103203256B (zh) * | 2006-07-19 | 2015-09-23 | 博纳基因技术有限公司 | 纳米口装置阵列:它们的制备以及在大分子分析中的应用 |
| WO2008022035A2 (en) * | 2006-08-10 | 2008-02-21 | The Scripps Research Institute | Methods for identifying cellular modulators of disaggregation activity or aggregation activity in an animal |
| US20080060778A1 (en) * | 2006-09-08 | 2008-03-13 | Abraham Velasco-Tellez | Binder composition and method of forming foundry sand cores and molds |
| US20090208965A1 (en) * | 2006-10-25 | 2009-08-20 | Ikonisys, Inc. | Automated method for detecting cancers and high grade hyperplasias |
| EP2944647A1 (en) | 2007-07-26 | 2015-11-18 | Cellay, Inc. | Highly visible chromosome-specific probes and related methods |
| US8951731B2 (en) | 2007-10-15 | 2015-02-10 | Complete Genomics, Inc. | Sequence analysis using decorated nucleic acids |
| JP2009178159A (ja) * | 2007-11-05 | 2009-08-13 | Hitachi Plant Technologies Ltd | 核酸配列の検出方法及び核酸配列検出基板 |
-
2008
- 2008-10-06 CN CN2008801193343A patent/CN101889074A/zh active Pending
- 2008-10-06 CA CA2701726A patent/CA2701726A1/en not_active Abandoned
- 2008-10-06 US US12/681,589 patent/US20100331195A1/en not_active Abandoned
- 2008-10-06 EA EA201000427A patent/EA201000427A1/ru unknown
- 2008-10-06 MX MX2010003724A patent/MX2010003724A/es unknown
- 2008-10-06 EP EP08835273A patent/EP2203547A4/en not_active Withdrawn
- 2008-10-06 AU AU2008308457A patent/AU2008308457A1/en not_active Abandoned
- 2008-10-06 JP JP2010528215A patent/JP2010539991A/ja active Pending
- 2008-10-06 KR KR1020107008686A patent/KR20100089060A/ko not_active Withdrawn
- 2008-10-06 WO PCT/US2008/078986 patent/WO2009046445A1/en not_active Ceased
-
2010
- 2010-04-02 US US12/753,702 patent/US20100267154A1/en not_active Abandoned
- 2010-04-02 US US12/753,712 patent/US20100267156A1/en not_active Abandoned
- 2010-04-02 US US12/753,696 patent/US20100267153A1/en not_active Abandoned
- 2010-04-02 US US12/753,693 patent/US8153438B2/en not_active Expired - Fee Related
- 2010-04-02 US US12/753,722 patent/US20100268478A1/en not_active Abandoned
- 2010-04-02 US US12/753,708 patent/US20100267155A1/en not_active Abandoned
- 2010-04-02 US US12/753,717 patent/US20100267157A1/en not_active Abandoned
- 2010-04-06 IL IL204866A patent/IL204866A0/en unknown
- 2010-04-23 ZA ZA2010/02881A patent/ZA201002881B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2701726A1 (en) | 2009-04-09 |
| WO2009046445A1 (en) | 2009-04-09 |
| CN101889074A (zh) | 2010-11-17 |
| EA201000427A1 (ru) | 2010-10-29 |
| JP2010539991A (ja) | 2010-12-24 |
| US20100267152A1 (en) | 2010-10-21 |
| ZA201002881B (en) | 2011-07-27 |
| US20100267155A1 (en) | 2010-10-21 |
| US20100331195A1 (en) | 2010-12-30 |
| KR20100089060A (ko) | 2010-08-11 |
| US20100267156A1 (en) | 2010-10-21 |
| EP2203547A1 (en) | 2010-07-07 |
| IL204866A0 (en) | 2010-11-30 |
| US20100267154A1 (en) | 2010-10-21 |
| US20100267153A1 (en) | 2010-10-21 |
| EP2203547A4 (en) | 2011-06-01 |
| MX2010003724A (es) | 2010-09-14 |
| US20100267157A1 (en) | 2010-10-21 |
| US20100268478A1 (en) | 2010-10-21 |
| US8153438B2 (en) | 2012-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8153438B2 (en) | Sequencing nucleic acid polymers with electron microscopy | |
| EP3004385B1 (en) | Nanopore-based nucleic acid analysis with mixed fret detection | |
| EP1543152B1 (en) | Controlled alignment of nanobarcodes encoding specific information for scanning probe microscopy (spm) reading | |
| EP1601791B1 (en) | Random array dna analysis by hybridization | |
| US20250320543A1 (en) | Method of translocating nucleic acids through nanopores | |
| EP1711625A2 (en) | Methods and compositions for detecting nucleic acids using scanning probe microscopy and nanocodes | |
| WO2014066902A1 (en) | Hybrid nanopore device with optical detection and methods of using same | |
| WO2010115122A2 (en) | Generation of uniform fragments of nucleic acids using patterned substrates | |
| WO2023130019A2 (en) | Spatial omics platforms and systems | |
| WO2013119784A1 (en) | Methods of sequencing nucleic acids using nanopores and active kinetic proofreading | |
| US5470707A (en) | Hydrogen bond labeling and base sequence determination methods for DNA or RNA | |
| EP1546983A2 (en) | Controlled aligment of nano-barcodes encoding specific information for scanning probe microscopy (spm) reading | |
| DK2217729T3 (en) | Method of concentrating nucleic acid molecules | |
| HK1152071A (en) | Sequencing nucleic acid polymers with electron microscopy | |
| WO2010144128A2 (en) | Molecular alignment and attachment of nucleic acid molecules | |
| WO2017075179A1 (en) | Sequencing by deconvolution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |